Impact

RECOVER makes study data compatible across research areas to amplify impact and findings. For example, findings from electronic health records (EHRs) and observational studies equipped us to design and launch evidence-based clinical trials.

0000 Million

EHRs analyzed

0000

observational study sites across

0000

states

0000

pathobiology studies

0000

potential treatments being tested across

0000

clinical trials

RECOVER is the world’s most comprehensive and diverse patient-centered research initiative studying Long COVID.

0000

new RECOVER participants

0000

from ongoing studies

0000

Long COVID community Representatives

0000

Long COVID community members involved in RECOVER study setup

0000

researchers and clinicians

RECOVER generates and broadly shares findings and data to foster new research opportunities and disseminate information to the broader community.

0000 Million

datapoints available to authorized researchers

0000

public research webinars

0000

peer-reviewed research publications

0000

newsletter subscribers

RECOVER Findings

Over the past three years, we have learned crucial information about Long COVID. Follow the links below to learn more about the multiple RECOVER studies that support each of these important findings.

The incredibly
broad range of clinical symptoms The effect of viral variants
on the risk for and severity of Long COVID The risk of developing
new-onset conditions and/or worsening of pre-existing conditions

Risk factors
for developing Long COVID The impact of vaccination
on Long COVID Health disparities
in Long COVID

If you want to learn more about the scientific discoveries made by RECOVER researchers, you can browse and search the complete list of RECOVER Publications.

You can also explore RECOVER Research Summaries, which use plain language and a format that is easy to understand.